LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 76.94 | 17.25 | 1405 | 5681 | 0.2473 | 0.6923 | MN20160310_N02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 76.94 | 17.25 | 5243 | 5681 | 0.9228 | 0.9809 | MN20160310_N02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 78.91 | 17.25 | 1 | 5730 | 0.0002 | -0.2882 | MN20160310_N02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 78.91 | 17.25 | 4101 | 5730 | 0.7156 | 0.9217 | MN20160310_N02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 78.91 | 17.25 | 1450 | 5730 | 0.2530 | 0.6974 | MN20160310_N02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 78.91 | 17.25 | 5427 | 5730 | 0.9470 | 0.9871 | MN20160310_N02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 80.88 | 17.25 | 4 | 5826 | 0.0007 | -0.1597 | MN20160310_N02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 80.88 | 17.25 | 4263 | 5826 | 0.7317 | 0.9270 | MN20160310_N02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 80.88 | 17.25 | 1256 | 5826 | 0.2156 | 0.6661 | MN20160310_N02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 80.88 | 17.25 | 5605 | 5826 | 0.9621 | 0.9908 | MN20160310_N02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 82.85 | 17.25 | 3 | 5861 | 0.0005 | -0.1878 | MN20160310_N02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 82.85 | 17.25 | 4397 | 5861 | 0.7501 | 0.9328 | MN20160310_N02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 82.85 | 17.25 | 1319 | 5861 | 0.2250 | 0.6749 | MN20160310_N02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 82.85 | 17.25 | 5815 | 5861 | 0.9920 | 0.9981 | MN20160310_N02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 84.82 | 17.25 | 1 | 5924 | 0.0002 | -0.2869 | MN20160310_N02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 84.82 | 17.25 | 4586 | 5924 | 0.7741 | 0.9401 | MN20160310_N02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 84.82 | 17.25 | 1277 | 5924 | 0.2156 | 0.6669 | MN20160310_N02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 84.82 | 17.25 | 5992 | 5924 | 1.0115 | 1.0027 | MN20160310_N02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 86.79 | 17.25 | 1 | 6008 | 0.0002 | -0.2863 | MN20160310_N02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 86.79 | 17.25 | 4744 | 6008 | 0.7896 | 0.9448 | MN20160310_N02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 86.79 | 17.25 | 1112 | 6008 | 0.1851 | 0.6378 | MN20160310_N02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 86.79 | 17.25 | 6134 | 6008 | 1.0209 | 1.0049 | MN20160310_N02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 88.76 | 17.25 | 1 | 6047 | 0.0002 | -0.2860 | MN20160310_N02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 88.76 | 17.25 | 4917 | 6047 | 0.8130 | 0.9516 | MN20160310_N02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 88.76 | 17.25 | 843 | 6047 | 0.1394 | 0.5842 | MN20160310_N02 | K11 |